Panagora Asset Management Inc Myriad Genetics Inc Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$16.45 - $25.88 $812,580 - $1.28 Million	49,397 Added 31.67%	205,382 $3.73 Million
Q1 2022 May 12, 2022	SELL	$22.67 - $28.01 $10,178 - $12,576	-449 Reduced 0.29%	155,985 $3.93 Million
Q4 2021 Feb 10, 2022	BUY	$24.13 - $32.63 $237,342 - $320,948	9,836 Added 6.71%	156,434 $4.32 Million
Q3 2021 Nov 10, 2021	BUY	$29.97 - $36.66 $9,560 - $11,694	319 Added 0.22%	146,598 $4.73 Million
Q2 2021 Aug 11, 2021	BUY	$25.39 - $32.61 $3.71 Million - $4.77 Million	146,279 New	146,279 $4.47 Million

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.09B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.